Intravenous Exposure to Amino-polystyrene Induces Excessive Autophagy and Apoptosis in Myocardium Through ROS Driven PI3K/AKT/mTOR Axis Authors: Wen Gou, Yujun Xie, Rui Xia, Ping Gou, Chunfeng Cao, Fujun Luan, Beizhong Liu, Yuan Li Published: 2026 ABSTRACT Polystyrene (PS) is a pervasive plastic whose threat to human health is growing, yet its cardiotoxicity, particularly under clinically relevant exposure scenarios, remains poorly understood. This study addresses this critical gap by modeling intravenous exposure to nanopolystyrene, simulating clinical situations where plastic-derived medical devices directly contact blood. We established an in vitro model using human AC16 cardiomyocytes and an in vivo model via tail vein injection in Balb/c mice to compare the effects of amino-modified (PS-NH₂), carboxyl-modified (PS-COOH), and unmodified (PS-Bare) polystyrene nanoparticles. Our findings demonstrate that PS-NH₂, in contrast to PS-COOH and PS-Bare, induces significant cardiotoxicity. This toxicity was initiated by a substantial increase in reactive oxygen species (ROS), which subsequently suppressed the PI3K/AKT/mTOR signaling axis. This inhibition led to the excessive activation of autophagy and the induction of apoptosis in cardiomyocytes. In vivo, PS-NH₂ exposure caused severe pathological changes in mouse hearts, confirming its potent cardiotoxicity, characterized by inflammation, an impaired oxidative-antioxidant balance, and adverse cardiac remodeling. Notably, these detrimental effects were substantially reversed by the ROS scavenger N-acetylcysteine (NAC) or ginsenoside Rb1. In conclusion, our study reveals that Polystyrene positively charged amino-modified during degradation is the key to its cardiotoxicity, operating through a ROS-driven PI3K/AKT/mTOR pathway. These findings underscore the potential risks associated with specific surface modifications of nanoplastics and provide crucial insights for developing therapeutic strategies against plastic-induced cardiac injury.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s12012-026-10180-1. Introduction Plastics, characterized by their cheap, light weight and durability, have seen their annual global consumption increase 200-fold over the past seven decades since industrialization. However, these materials are not fully biodegradable and instead degrade into microplastics (MPs, < 5 mm) and nanoplastics (NPs, < 100 nm) through physical, photolytic, chemical, and biological processes. This degradation alters their chemical properties, leading to modifications that impart distinct surface charges, which in turn dictate their biological interactions. Humans are exposed to micro- and nanoplastics (MNPs) primarily through inhalation, ingestion, and dermal contact, with adults estimated to ingest 0.1–5 g of plastics daily, and blood concentrations reaching as high as 1.6 µg/mL [1]. Alarmingly, plastic particles have now been detected in virtually all human organs [2–6]. While extensive research has focused on aquatic and cold-blooded species, studies on mammals remain limited. Critically, an emerging and underestimated exposure route is iatrogenic, where invasive medical procedures—including vascular interventions, critical care catheterization, permanent artificial implants, and intravenous infusions—significantly and rapidly elevate blood plastic levels in patients [7, 8]. This direct intravascular entry bypasses the traditional respiratory, gastrointestinal, and dermal barriers, potentially triggering pathogenic mechanisms distinct from those of conventional exposure routes. A limited number of studies have reported that MNPs administered via drinking water accumulate in the myocardium of mice [9]. Clinically, elevated plastic levels are detected in human blood following cardiac surgery or endovascular interventions [7, 10]. Experimental evidence indicates that MNPs induce a range of pathological cardiac alterations, including excessive oxidative stress, inflammation, apoptosis, and fibrosis [11]. Furthermore, plastics have been shown to cause cardiac developmental defects in zebrafish [12], reduce myocardial contractility in neonatal mice [9], and trigger arrhythmias in human cardiomyocytes [13]. Specifically, elevated MNPs levels strongly associated with an increased risk of major adverse cardiac events (MACE) post-myocardial infarction in humans [14]. Despite these findings, research on MNP-induced cardiotoxicity remains fragmented, and the underlying pathogenic mechanisms are largely elusive. Autophagy is a highly conserved cellular process essential for maintaining homeostasis through the lysosomal degradation of damaged organelles, aberrant macromolecules, and foreign substances. In the myocardium, basal autophagy is critical for cellular quality control and survival, while its dysregulation is implicated in various cardiac pathologies [15, 16]. Interestingly, transcriptomic analyses following nanoplastic exposure have consistently identified the induction of autophagy and perturbation of the PI3K/AKT signaling pathway as prominent cellular responses [17, 18]. However, it remains unclear whether the myocardial alterations induced by specifically amino-modified nanoplastics (PS-NH₂) are mediated through this PI3K/AKT-autophagy axis. Excessive generation of reactive oxygen species (ROS) is a well-established hallmark of the cellular response to MNPs. The ROS scavenger N-acetylcysteine (NAC) has demonstrated efficacy in partially reversing MPs-induced cellular damage [19, 20]. Nevertheless, the precise role of ROS in PS-NH₂-mediated cardiotoxicity and its position in the potential signaling cascade remain to be elucidated. In parallel, there is a pressing need for effective therapeutic countermeasures. Ginsenoside Rb1, a pharmacologically active component of traditional Chinese medicine known for its antioxidant properties, emerges as a promising candidate for mitigating PS-NH₂-induced cardiac injury, warranting further investigation. Materials and Methods Nanoparticle Characterization Aminated (PS−NH2), carboxyl-modified (PS−COOH), and unmodified bare (PS−Bare) polystyrene nanoparticles (nominal diameter: 50 nm) were purchased from Zhongkeleiming Daojin Technology Co., (Beijing, China). The morphology and size of the nanoparticles were examined using Transmission Electron Microscopy (TEM; JEM-F200, JEOL, Japan). For TEM analysis, particles were dispersed in ethanol via sonication (50 W, 30 min; Xiyang Instrument Co., Shanghai, China), deposited onto copper grids, and imaged at an accelerating voltage of 200 kV. Zeta potential was measured using a Zetasizer Nano ZS90 (Malvern Panalytical, UK). Before all experiments, particle suspensions were sonicated for 5 min to ensure monodispersion. Cell Culture and Treatment Human AC16 cardiomyocytes were obtained from Xin Zhou Biotechnology (Shanghai, China; product number: ZQ0960). Cells were cultured in DMEM/F12 medium (Gibco, USA) supplemented with 10% fetal bovine serum (Gibco, USA) and 1% penicillin–streptomycin (Biosharp, China). They were maintained in a humidified incubator at 37℃ with 5% CO2. Upon reaching approximately 80% confluence, cells were subjected to various treatments. Cell Viability Assay 1 × 104 AC16 cells per well were seeded in a 96-well plate and allowed to adhere. After reaching 80% confluence, cells were treated with different types of PS at concentrations of 7.5, 15, 30, or 60 µg/mL for 8, 16, or 24 h. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8; Beyotime, Shanghai, China). Briefly, 10 µL of CCK-8 solution was added to each well, and after a 1-h incubation at 37℃, the optical density (OD) was measured at 450 nm using a microplate reader (Varioskan Flash, Thermo Fisher, USA). The concentration resulting in approximately 70% cell viability (IC70) was determined for subsequent experiments. Assessment of Cell Death, Autophagy, and Reactive Oxygen Species (ROS) Cell death was quantified using an Annexin V-FITC/PI Apoptosis Detection Kit (Nanjing Kaiji Biotechnology Development Co., Ltd., Nanjing, China) and a Lactate Dehydrogenase (LDH) Release Assay Kit (Beyotime, Shanghai, China). For flow cytometry, cells were stained with Phycoerythrin (PE)-labeled Annexin V and Propidium Iodide (PI) according to the manufacturer’s protocol and analyzed using a CytoFLEX flow cytometer (Beckman Coulter, USA). LDH activity in the cell culture supernatant was measured as per the kit instructions. Intracellular ROS levels were detected using 2′,7′-dichlorofluorescin diacetate (DCFH-DA; Beyotime, Shanghai, China) at a final concentration of 2.5 µM. Fluorescence intensity was observed under an inverted fluorescence microscope (IX71, Olympus, Japan) and quantified by flow cytometry. Autophagic flux was monitored using an Ad-mCherry-GFP-LC3B adenoviral probe (Beyotime, Shanghai, China). Cells were transfected with the adenovirus for 24 h, followed by treatment as designated. Fluorescence signals were observed at 4, 8, and 16 h post-treatment. Animal Model and Experimental Design All animal experiments were conducted in strict accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8023, revised 1978) and the ARRIVE Guidelines 2.0. The protocol was approved by the Ethics Committee of Chongqing Medical University (IACUC-CQMU-2024–05026). Male BALB/c mice (8 weeks old, 20–25 g) were purchased from the Laboratory Animal Center of Chongqing Medical University (license: SCXK(YU)2018-0003) and housed under standard conditions with a 12-hour light/dark cycle and ad libitum access to food and water. Forty mice were randomly divided into five groups (n = 8 per group): (1) Control, (2) PS−NH2, (3) PS−COOH, (4) PS−Bare, and (5) PS−NH2 + Rb1. PS nanoparticles were administered via tail vein injection at a dose of 1 µg/g body weight every 48 h for a total of 10 injections, a regimen designed to approximate the in vitro concentration of 15 µg/ml. The control group received an equivalent volume of medical saline. In the PS−NH2 + Rb1 group, Ginsenoside Rb1 was administered via tail vein injection at a dose of 50 µg/g body weight on the next day following each PS−NH2 injection. Cardiac function was evaluated by transthoracic echocardiography on the day after the final injection, after which mice were euthanized for tissue and plasma collection. Transthoracic Echocardiography Mice were anesthetized with 1.5% isoflurane delivered via a nose cone, maintaining a respiratory rate of 50–80 breaths/min to ensure stable hemodynamics. The chest was depilated, and the skin was cleaned with 70% ethanol. Mice were placed supine on a heated platform (40℃) with a slight head-up tilt (10–15°) to optimize cardiac imaging. A probe was positioned at the left sternal border to visualize the left ventricle (LV), aortic root, and mitral valve. M-mode measurements were obtained at the papillary muscle level to assess left ventricular internal diastolic diameter (LVIDd), fractional shortening (FS), ejection fraction (EF), interventricular septum thickness (IVSs and IVSd), and left ventricular posterior wall thickness (LVPWs and LVPWd). Histological and Immunohistochemical Analysis Heart samples were rapidly excised and fixed in 4% paraformaldehyde overnight. The tissues were then embedded in paraffin and sectioned at 4 μm thickness. For general morphology, sections were stained with Hematoxylin and Eosin (H&E) and Masson’s trichrome stain. For immunohistochemistry (IHC), sections were deparaffinized, rehydrated, and subjected to antigen retrieval. After blocking with 10% donkey serum for 2 h at room temperature, sections were incubated overnight at 4℃ with a primary antibody against Collagen I (1:500, ab270993, Abcam). Subsequently, sections were incubated with HRP-conjugated donkey anti-rabbit IgG for 2 h at room temperature. Images were captured using a microscope (IX71, Olympus, Japan). Western Blot Analysis Cells and heart tissues were lysed in RIPA (Radio Immunoprecipitation Assay Buffer) lysis buffer supplemented with protease and phosphatase inhibitors (Beyotime). Protein concentrations were determined, and equal amounts of protein (20–40 µg) were separated by 10% or 6% SDS-PAGE and transferred onto 0.22–0.45 μm PVDF membranes (Merck-Millipore). The membranes were blocked with 5% non-fat milk for 1 h at room temperature and then incubated with specific primary antibodies (detailed in supplementary material) overnight at 4℃. The detailed list of antibodies is provided in Table S1. After washing, the membranes were incubated with HRP-conjugated secondary antibodies for 2 h at room temperature. Protein bands were visualized using enhanced chemiluminescence (ECL) reagent (Merck-Millipore), and band density was semi-quantified using ImageJ software. Statistical Analysis Western blot and fluorescence quantification data were analyzed using ImageJ (1.53e), and flow cytometry data were processed with FlowJo (v10.8.1). All continuous variables are presented as mean ± standard deviation (SD). Graphs were generated using OriginPro 2021, GraphPad Prism 10.1, and Microsoft Excel. Statistical differences between multiple groups were evaluated using a one-way analysis of variance (ANOVA). A p-value of less than 0.05 was considered statistically significant. Results Particle Characterization and In Vitro Cytotoxicity of Differently Modified PS Nanoparticles We first characterized the physicochemical properties of the polystyrene nanoparticles. The zeta potentials for amino-modified (PS−NH2), carboxyl-modified (PS−COOH), and unmodified (PS−Bare) particles were measured at 34.2 ± 5.52 mV, − 20.6 ± 3.69 mV, and − 0.663 ± 4.94 mV, respectively. All particles exhibited a nominal diameter of 50 nm, with standard deviations of ± 17.32 nm for PS−NH2, ± 16.99 nm for PS−COOH, and ± 18.81 nm for PS−Bare (Fig. 1A). To assess their cytotoxicity, human AC16 cardiomyocytes were exposed to these particles. Our findings revealed that PS−NH2 exposure at 15 µg/mL for 16 h significantly reduced cell viability to approximately 70%, whereas PS−COOH and PS−Bare did not induce a significant decrease under the same conditions (Fig. 1B and C). To evaluate the effect of nanoparticles on the functional integrity of cell membranes, we measured lactate dehydrogenase (LDH) release, which showed substantial leakage from AC16 cells starting at a concentration of 15 µg/mL for PS−NH2. This significant increase in extracellular LDH activity confirmed the acute cytotoxicity and membrane damage induced by PS−NH2 nanoparticles (Fig. 1D). Concurrently, marked alterations in cellular morphology were observed in the PS−NH2 (See supplementary materials). Fig. 1A Zeta and diameters distribution of PS-NH2, PS-COOH and PS-Bare. B Cell viability of PS with different modifications under different concentrations and durations. C Cell viability of PS with different modifications under different concentrations for 16 h. D The Lactate Dehydrogenase (LDH) release levels of different PS modifications after 16 h of intervention with different concentrations. Values are expressed as mean ± SD of three independent experiments A Zeta and diameters distribution of PS-NH2, PS-COOH and PS-Bare. B Cell viability of PS with different modifications under different concentrations and durations. C Cell viability of PS with different modifications under different concentrations for 16 h. D The Lactate Dehydrogenase (LDH) release levels of different PS modifications after 16 h of intervention with different concentrations. Values are expressed as mean ± SD of three independent experiments PS−NH2 Induces Excessive ROS and Autophagy via Inhibition of the PI3K/AKT/mTOR Pathway A bibliometric analysis of “polystyrene”-related studies from the last five years identified “ROS” as the keyword with the highest frequency and link strength, highlighting its important role in polystyrene toxicity research (see supplementary materials). Experimentally, we stained PS-exposed cells with DCFH-DA (2’,7’-Dichlorodihydrofluorescein Diacetate) to measure intracellular ROS levels. Both fluorescence microscopy and flow cytometry demonstrated that PS−NH2 induced the highest level of ROS generation among all tested particle types. (Figure 2C and D) Biological transmission electron microscopy (TEM) was employed to investigate the subcellular consequences of nanoplastic exposure. In PS−NH2 group, we observed not only the internalization of PS particles but also the formation of numerous typical autophagosomes, as well as early and late autolysosomes. In contrast, PS−COOH and PS−Bare groups, despite internalizing the particles, showed no autophagosome formation (Fig. 2A). Subsequent Western blot analysis corroborated these morphological findings, revealing a significantly elevated LC3B-II/I (Microtubule-Associated Protein 1 Light Chain 3B) ratio, increased Beclin-1 levels, and decreased p62 levels in the PS−NH2-treated group (Fig. 2B). To assess autophagic flux, cells were transfected with an Ad-mCherry-GFP-LC3B probe. This assay demonstrated massive autophagosome formation at 8 h and a subsequent decrease in GFP (Green Fluorescent Protein) signals by 16 h in the PS−NH2 group, indicating an activated autophagic flux (Fig. 3B). Furthermore, analysis of the PI3K/AKT/mTOR (Phosphatidylinositol 3-kinase/Protein kinase B/mammalian target of rapamycin) pathway revealed a downregulation of PI3K-p85, phosphorylated AKT (p-AKT(S473)), and phosphorylated mTOR (p-mTOR(S2448)) following 16-hour PS−NH2 exposure (Fig. 3A). To confirm pathway dependency, we used the AKT activator SC79. Treatment with SC79 significantly reversed the expression of p-AKT, p-mTOR, Beclin1, LC3B-II/I, and p62 (Fig. 3C), confirming that PS−NH2 -induced autophagy was predominantly mediated through the inhibition of the PI3K/AKT/mTOR axis. Fig. 2A PS internalization and intracellular characteristic in different PS group in TEM. B Beclin-1/LC3B/p62 expression in different PS group. C ROS fluorescence and statistics in different PS groups at different time points. D Flow cytometric analysis of ROS fluorescence intensity in different PS groups. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm, 5 μm A PS internalization and intracellular characteristic in different PS group in TEM. B Beclin-1/LC3B/p62 expression in different PS group. C ROS fluorescence and statistics in different PS groups at different time points. D Flow cytometric analysis of ROS fluorescence intensity in different PS groups. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm, 5 μm Fig. 3A PI3K/AKT/mTOR pathway protein expression in different PS group. B Fluorescence of Ad-mCherry-GFP-LC3B transfected cells after PS-NH2 intervention at different time points. C AKT/mTOR and Beclin-1/LC3B/p62 expression after SC79 activates AKT in PS-NH2 group. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm, 5 μm A PI3K/AKT/mTOR pathway protein expression in different PS group. B Fluorescence of Ad-mCherry-GFP-LC3B transfected cells after PS-NH2 intervention at different time points. C AKT/mTOR and Beclin-1/LC3B/p62 expression after SC79 activates AKT in PS-NH2 group. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm, 5 μm PS−NH2 Promotes Apoptosis in Cardiomyocytes Simultaneously, we evaluated cell apoptosis using Annexin-V/PI staining. This analysis revealed increased membrane permeability and extensive nuclear staining in the PS−NH2 group, with flow cytometry indicating substantial cell death, predominantly in the late stage (Fig. 4A). Western blot analysis confirmed the upregulation of key apoptotic executor proteins, including caspase-9 (Cysteine Aspartyl Protease-9), caspase-3 (Cysteine Aspartyl Protease-3), and PARP (Poly (ADP-ribose) polymerase), in the PS−NH2 group (Fig. 4B). Notably, the application of the AKT activator SC79 reversed the elevated of these apoptotic markers, suggesting that PS−NH2 -induced apoptosis occurs downstream of AKT suppression (Fig. 4C). Fig. 4A Flow cytometry of Annexin-V/PI staining in different PS group. B Caspase-9/Bax/bcl-2/Caspase-3/PARP expression in different PS group. C Caspase-9/Bax/bcl-2/Caspase-3/PARP expression in PS-NH2 and SC79 activation group. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 A Flow cytometry of Annexin-V/PI staining in different PS group. B Caspase-9/Bax/bcl-2/Caspase-3/PARP expression in different PS group. C Caspase-9/Bax/bcl-2/Caspase-3/PARP expression in PS-NH2 and SC79 activation group. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 Reactive Oxygen Species (ROS) Act as the Upstream Trigger for PS−NH2-Induced Toxicity, Pharmacological Interventions Targeting the ROS-Autophagy Axis Mitigate Cellular Toxicity To dissect the mechanistic role of ROS in the autophagy-apoptosis cascade, we treated cells with the ROS scavenger N-acetylcysteine (NAC), ginsenoside Rb1, SC79, or the lysosomal enzyme inhibitor E-64d. NAC and Rb1 reversed PS-induced ROS elevation (Fig. 5A and B). Western blot analysis showed that both NAC and Rb1 effectively reversed the PS−NH2 -induced alterations in the PI3K/AKT/mTOR pathway, autophagy markers (Beclin-1, p62, LC3B-II/I), and apoptosis markers (caspase-3, PARP), suggest that ROS is maybe the primary trigger for this pathological cascade. In contrast, E-64d administration led to a substantial reversal of p62 accumulation but did not affect the LC3B-II/I ratio, indicating that E-64d blocked the degradation of autophagic substrates within autolysosome without preventing autophagosome formation (Fig. 5C). The observation that E-64d also reversed the expression of caspase-3 and PARP suggests that cell death affected by autophagy cascade (Fig. 6A). These findings were further supported by autophagic flux assays, where NAC and Rb1 inhibited autophagosome formation, whereas E-64d resulted in the accumulation of autophagosomes with undegraded GFP fluorescence, confirming the blockade of autolysosomal degradation (Fig. 5D). Finally, flow cytometry analysis showed that NAC, Rb1, E-64d, and SC79 all inhibited cell death to varying degrees, with E-64d showing a particularly strong suppressive effect(Fig. 6B). Those findings position ROS as a pivotal trigger for PS-NH2 induced effects. Fig. 5A ROS fluorescence and analysis in PS-NH2 with or without NAC/Rb1/SC79 at different time points. B Flow cytometric analysis of ROS fluorescence intensity in PS-NH2 with or without NAC/Rb1/SC79. C Influence of NAC/Rb1/E-64d on PI3K/AKT/mTOR pathway and Beclin-1/LC3B/p62 protein expression induced by PS-NH2. D Influence of NAC/Rb1/E-64d/SC79 on autophagy flux. Red asterisks denote comparison with control group. Black asterisks denote comparison with the PS–NH₂ group. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 5 μm A ROS fluorescence and analysis in PS-NH2 with or without NAC/Rb1/SC79 at different time points. B Flow cytometric analysis of ROS fluorescence intensity in PS-NH2 with or without NAC/Rb1/SC79. C Influence of NAC/Rb1/E-64d on PI3K/AKT/mTOR pathway and Beclin-1/LC3B/p62 protein expression induced by PS-NH2. D Influence of NAC/Rb1/E-64d/SC79 on autophagy flux. Red asterisks denote comparison with control group. Black asterisks denote comparison with the PS–NH₂ group. The concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 5 μm Fig. 6A Influence of NAC/Rb1/E-64d on caspase-9/BAX/bcl-2/caspase-3/PARP expression induced by PS-NH2. B Flow cytometric analysis of cell death in PS-NH2 with or without NAC/Rb1/E-64d/SC79. Red asterisks denote comparison with control group. Black asterisks denote comparison with the PS–NH₂ group. Unless otherwise stated, the concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 5 μm A Influence of NAC/Rb1/E-64d on caspase-9/BAX/bcl-2/caspase-3/PARP expression induced by PS-NH2. B Flow cytometric analysis of cell death in PS-NH2 with or without NAC/Rb1/E-64d/SC79. Red asterisks denote comparison with control group. Black asterisks denote comparison with the PS–NH₂ group. Unless otherwise stated, the concentration of PS was 15 µg/ml and the treatment time was 16 h. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 5 μm PS−NH2 Exposure Disrupts Myocardial Homeostasis In Vivo Next, we validated our in vitro findings in an in vivo model via intravenous injection. TEM examination of myocardial tissue from PS−NH2 -exposed mice revealed the presence of internalized PS particles and characteristic autophagosomes within cardiomyocytes (Fig. 7A). Western blot analyses of myocardial protein extracts confirmed a significant increase in the LC3B-II/I ratio and Beclin-1 expression, alongside a reduction in p62 levels (Fig. 7C). Concurrently, the PI3K/AKT/mTOR signaling pathway was suppressed, and the apoptotic executors cleaved caspase-3 and PARP were upregulated in the PS−NH2 group (Fig. 7B). Consistent with the in vitro results, co-administration of ginsenoside Rb1 significantly reversed these PS−NH2 -induced molecular alterations, confirming its cardioprotective effect in vivo (Fig. 8A and B). Fig. 7A PS-NH2 internalization and intracellular characteristics in mice myocardium. B Caspase-9/BAX/bcl-2/caspase-3/PARP expression in different PS group of mice myocardium. C PI3K/AKT/mTOR and Beclin-1/LC3B/p62 expression in different PS group of mice myocardium. PS nanoparticles were administered via tail vein injection at a dose of 1 µg/g body weight every 48 h for a total of 10 injections. Ginsenoside Rb1 was administered via tail vein injection at a dose of 50 µg/g body weight on the next day following each PS−NH2 injections. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm A PS-NH2 internalization and intracellular characteristics in mice myocardium. B Caspase-9/BAX/bcl-2/caspase-3/PARP expression in different PS group of mice myocardium. C PI3K/AKT/mTOR and Beclin-1/LC3B/p62 expression in different PS group of mice myocardium. PS nanoparticles were administered via tail vein injection at a dose of 1 µg/g body weight every 48 h for a total of 10 injections. Ginsenoside Rb1 was administered via tail vein injection at a dose of 50 µg/g body weight on the next day following each PS−NH2 injections. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm Fig. 8A PI3K/AKT/mTOR and Beclin-1/LC3B/p62 expression in PS-NH2 with or without Rb1. B Caspase-9/BAX/bcl-2/caspase-3/PARP expression in PS-NH2 group with or without Rb1 of mice myocardium. PS nanoparticles were administered via tail vein injection at a dose of 1 µg/g body weight every 48 h for a total of 10 injections. Ginsenoside Rb1 was administered via tail vein injection at a dose of 50 µg/g body weight on the next day following each PS−NH2 injections. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm A PI3K/AKT/mTOR and Beclin-1/LC3B/p62 expression in PS-NH2 with or without Rb1. B Caspase-9/BAX/bcl-2/caspase-3/PARP expression in PS-NH2 group with or without Rb1 of mice myocardium. PS nanoparticles were administered via tail vein injection at a dose of 1 µg/g body weight every 48 h for a total of 10 injections. Ginsenoside Rb1 was administered via tail vein injection at a dose of 50 µg/g body weight on the next day following each PS−NH2 injections. Values are expressed as mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 1 μm Inflammation, Oxidative Stress, and Histopathological Alterations In Vivo We further investigated the broader pathological consequences of PS−NH2 exposure in the myocardium. We detected significantly elevated levels of pro-inflammatory cytokines, including IL-6, IL-1β, and TNF-α, in the heart tissue of PS−NH2 -exposed mice (Fig. 9C). Serum analysis revealed a heightened state of oxidative stress, indicated by increased malondialdehyde (MDA) and decreased activities of key antioxidant enzymes, including total antioxidant capacity (T-AOC), total superoxide dismutase (T-SOD), catalase (CAT), and the GSH/tGSH ratio (Fig. 9D). These pathological changes were substantially reversed by ginsenoside Rb1 (Fig. 9E). Histopathological examination by H&E staining demonstrated myocardial cytoplasmic pallor and nuclear pyknosis, while Masson’s trichrome staining and collagen I immunohistochemistry confirmed fibrinogen deposition, indicating that PS−NH2 -triggered myocarditis progressing to fibrosis (Fig. 9A). Interestingly, the right ventricle was consistently identified as the most severely affected region. Cardiac Dysfunction Induced by PS−NH2 Exposure Finally, we assessed cardiac morphology and function using transthoracic echocardiography. The results revealed that exposure to PS−NH2 caused thinning of the interventricular septum and the left ventricular posterior wall, accompanied by a declining trend in ejection fraction (EF). In contrast, exposure to PS−COOH and PS−Bare resulted in myocardial wall thickening (Fig. 9B). This dichotomous response aligns with known dynamics of inflammatory cardiomyopathy, where mild stress can induce adaptive concentric hypertrophy (wall thickening), while severe stress drives maladaptive eccentric dilation (wall thinning). Fig. 9A H&E, Masson stain and immunohistochemistry of collagen I in Control, PS-NH2 and PS-NH2+Rb1 group of mice myocardium. Blue arrows indicate abnormal cytoplasm; Green arrows indicate collagen fibers; Red arrows indicate collagen fibers. B Ultrasound assessment of control, PS-NH2, PS-NH2+Rb1, PS-COOH and PS-Bare group of mice heart. C, D IL-6, IL-1β and TNF-α in control, PS-NH2, PS-NH2+Rb1 group of mice myocardium. E Total antioxidation (TAO), Superoxide Dismutase (SOD), Catalase (CAT), Glutathione (GSH) and Malondialdehyde (MDA) in mice serum of control, PS-NH2, PS-NH2+Rb1, PS-COOH and PS-Bare group. PS nanoparticles were administered via tail vein injection at a dose of 1 µg/g body weight every 48 h for a total of 10 injections. Ginsenoside Rb1 was administered via tail vein injection at a dose of 50 µg/g body weight on the next day following each PS−NH2 injections. Values are expressed as mean ± SD of three independent experiments. Values are expressed as mean ± SD, N = 3. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 100 μm, 1 mm A H&E, Masson stain and immunohistochemistry of collagen I in Control, PS-NH2 and PS-NH2+Rb1 group of mice myocardium. Blue arrows indicate abnormal cytoplasm; Green arrows indicate collagen fibers; Red arrows indicate collagen fibers. B Ultrasound assessment of control, PS-NH2, PS-NH2+Rb1, PS-COOH and PS-Bare group of mice heart. C, D IL-6, IL-1β and TNF-α in control, PS-NH2, PS-NH2+Rb1 group of mice myocardium. E Total antioxidation (TAO), Superoxide Dismutase (SOD), Catalase (CAT), Glutathione (GSH) and Malondialdehyde (MDA) in mice serum of control, PS-NH2, PS-NH2+Rb1, PS-COOH and PS-Bare group. PS nanoparticles were administered via tail vein injection at a dose of 1 µg/g body weight every 48 h for a total of 10 injections. Ginsenoside Rb1 was administered via tail vein injection at a dose of 50 µg/g body weight on the next day following each PS−NH2 injections. Values are expressed as mean ± SD of three independent experiments. Values are expressed as mean ± SD, N = 3. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bar: 100 μm, 1 mm Discussions Simulating clinically relevant scenarios where plastic medical devices directly contact patient blood [7, 8], we employed an intravenous injection model in mice, which bypassing traditional physiological barriers like the respiratory or digestive tracts. Our research reveals a strong correlation between 50 nm amino-modified polystyrene nanoparticles (PS − NH₂) and the occurrence of acute myocardial injury, which is characterized by excessive autophagy and apoptosis, a pathological cascade initiated by reactive oxygen species (ROS) and mediated through the inhibition of the PI3K/AKT/mTOR axis, while carboxyl-modified (PS-COOH) and unmodified (PS-Bare) particles showed no strong correlation with significant detrimental effects under our experimental conditions. This highlights a correlation between nanoparticle surface modification and their biological interactions. The dichotomous effects observed with different surface modifications provide crucial insights into the potential pathogenesis of nanoplastic-induced cardiotoxicity by identifying strong correlations between surface modification types and cardiac responses. We found that PS−NH2 exposure led to the thinning of the interventricular septum and left ventricular posterior wall, indicative of maladaptive eccentric dilation. In contrast, PS-COOH and PS-Bare exposure induced myocardial wall thickening, a pattern consistent with compensatory concentric hypertrophy. This response mirrors the biphasic nature of myocarditis, where mild stress promotes adaptive remodeling, whereas severe stress drives maladaptive changes and functional decline. These observations underscore a strong correlation between surface modification and nanoplastic-cardiac interactions, a consideration of paramount importance for environmental risk assessment. Our results are largely consistent with emerging evidence on the cardiotoxic potential of micro- and nanoplastics (MNPs), where correlation is frequently reported between MNPs exposure and the triad of oxidative stress, apoptosis, and myocardial fibrosis [11]. However, our study offers a more nuanced, mechanism-driven perspective by clarifying the correlation between PS − NH₂ exposure and the ROS/PI3K/AKT/mTOR axis. While a prior study reported lysosomal membrane permeabilization and autophagic flux blockade with PS−NH2 [21], it used a concentration (50 µg/mL) vastly exceeding realistic human blood level. This suggests potential threshold-dependent biphasic responses, where lower doses may trigger a transient activation of autophagy, as we observed, whereas higher doses overwhelm cellular homeostatic mechanisms and block the process. Furthermore, we found N-acetylcysteine (NAC) or ginsenoside Rb1 partially reversed PS − NH₂-induced toxicity, NAC, a direct ROS scavenger, offered substantial protection, the comparatively weaker but still significant efficacy of ginsenoside Rb1, not only provide additional evidence supporting excessive oxidative stress as a key step underlying PS-elicited cardiac toxicity, but also for the first time uncover the cardioprotective property among conventional herbal-derived components. Despite these significant findings, our study has several limitations that warrant consideration and define trajectories for future research. Firstly, the study was limited to a short-term intervention model, long-term exposure studies are necessary to understand the chronic impacts of nanoplastics on cardiac health [22–24]. Secondly, our investigation focused exclusively on spherical polystyrene particles, Given the vast diversity of plastics (e.g., polyethylene, polypropylene), various shapes & sizes, and in-vivo aggregation, aging and protein-corona formation of nanoparticles may collectively affect their biological effects. Certain observations suggest the involvement of non-canonical cell death pathways, as morphological analysis revealed partial cellular rupture inconsistent with classical apoptosis or autophagy. There are still many important knowledge gaps in the understanding of the impact of microplastics on human health. First and foremost, the detection technologies for microplastics are immature and non-uniform, there is a huge risk of microplastic contamination in multiple stages of detection [25], leading to significant differences in detection results. Secondly, there is a paucity of real-world research, and greater and urgent attention is warranted on some high-pollution risk population, such as garment manufacturing [26], waste management [27], metal mining [28], systemic health, including cardiac health in those population, requires more attention. Finally, eliminating or mitigating the impact of microplastics on human health is the ultimate objective, pollution source pretreatment [29], bacterial sequestration of microplastics [30], adsorption by hollow nanotubes or magnetic materials [31, 32], and promotion of microplastic excretion [33] are promising strategies. Conclusions In conclusion, this work provides compelling evidence that PS−NH2 nanoparticles pose a specific and significant threat to the myocardium by triggering ROS-driven inhibition of the PI3K/AKT/mTOR axis, leading to excessive autophagy and apoptosis. These findings offer a crucial mechanistic framework for understanding nanoplastic-induced cardiotoxicity and highlight surface charge as a very determinant of their pathogenic potential. Importantly, our validation of NAC and ginsenoside Rb1 as effective protective agents opens avenues for potential therapeutic interventions. Collectively, these results serve as a critical warning regarding the application of aminated nanoplastics in medical contexts and underscore the urgent need for comprehensive safety assessments of nanomaterials. Supplementary Information Below is the link to the electronic supplementary material.Supplementary material 1 (PDF 418.8 kb) Supplementary material 1 (PDF 418.8 kb)